Vertical Transmission

AIDS Placebo Trial Results Due in January 1998

Published in Medical Letter on the CDC and FDA, December 22nd, 1997

Drug trials to cut the rate of mother-to-child transmission of the virus that leads to AIDS will be completed by January 1998, leading health experts said.

Trials in Thailand, Ivory Coast, and elsewhere that use a short treatment of the drug AZT aim to prevent women passing on HIV to their babies during the final stages of pregnancy.

AZT is an anti-retroviral drug designed by Glaxo Wellcome to prevent the onset of AIDS in people with HIV.

"The Thailand trials will be completed in early January. The results will be out a couple of months later after follow-up work," said Stefan Wiktor, who leads AIDS research in Ivory Coast for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1997-12-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry